InvestorsHub Logo

scottsmith

11/03/15 9:04 PM

#29752 RE: imho #29751

What would the patent office have to do with how the drug works or trials? fda on the other hand...

kc2code

11/03/15 9:11 PM

#29756 RE: imho #29751

as far as safety, that was the primary objective of the phase 1 study.

http://www.anavex.com/?news=anavex-announces-positive-phase-1-data-for-anavex-2-73-lead-candidate-for-the-treatment-of-alzheimers

I don't believe Anavex even gets to run the Phase 2 unless phase 1 shows safety?

Also unsure if the FDA ever comments publicly on a drug trial/company unless it's for final approval or a safety warning?

this is my understanding in general and there are many on this board that are far more expert than I.